Shoulder Fractures
26
4
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
3.8%
1 terminated out of 26 trials
83.3%
-3.2% vs benchmark
12%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (26)
OsseoFit Stemless Shoulder System (Anatomic)
MDR - Comprehensive Primary Revision Stems PMCF
Zimmer Biomet Shoulder Arthroplasty PMCF Study
Continuous vs Liposomal Bupivacaine Interscalene Block for Proximal Humeral Fracture (CLIP)
Radiologist-Integrated Finite Element Framework for Acromial Stress in Reverse Shoulder Arthroplasty
Clinical Decision Rule for Excluding Shoulder Fractures
Zimmer Biomet Shoulder Arthroplasty PMCF
Efficacy of Early Multimodal Physiotherapy in Patients With Reverse Shoulder Prosthesis
MDR - Comprehensive Reverse/Versa Dial Ti Glenosphere
MDR - Comprehensive Primary/Micro Stem & Versa-Dial Ti Humeral Head
Surgical Versus Non-surgical Treatment of Displaced Proximal Humerus Fracture in Adults Aged 50 to 65 Years
Rehabilitation Following Displaced Proximal Humerus Fractures
Management of Proximal Humerus Fractures in Adults: a Clinical Trial
Plate Fixation Versus Intramedullary Nailing of 3 and 4 Part Proximal Humerus Fractures
Post Market Clinical Follow-up Study for Arthroplasty Shoulder System of FX Solutions at the Long Term
X-Ray Follow-up in Proximal Humeral Fractures Conservatively Treated
Continuous Interscalene Block vs Liposomal Bupivacaine After Proximal Humerus Fracture Surgery
RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures
A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture Shoulder System for Proximal Humerus Fractures
Targon PH+ Follow-Up